Abstract
We studied the effects of Al and Fe on bone metabolism in vivo and in vitro using nitrilotriacetic acid (NTA) as a chelator. We have reported experimental osteopathy in growing rats (6 weeks). In the present study, we used adult Wistar rats (15 weeks). Both Al-NTA (3.0 mg Al/kg) and Fe-NTA (6.0 mg Fe/kg) caused renal insufficiency and osteomalacia. Osteoid volume was 65.79±5.25% in Al-treated rats, 3.97±2.25% in Fe-treated rats and 2.22±0.77% in the control rats. The impairment of bone mineralization was detected in Al- and Fe-treated rats. The osteoidosis induced by Al-NTA in adult rats was much severer than that in growing rats. Osteomalacia was not induced by Fe-NTA in growing rats, but moderate osteomalacia was induced in adult rats. Therefore, an age-related change of the bone metabolism was suggested. The direct effects of these metals were also examined using an osteoblast-like cell line (HuO9) in vitro. The collagen synthesis was kept constant between Al and Fe concentration of 10−6 and 10−4 M, although ALP activity was decreased by Al and Fe. The results of this study demonstrate that Al- and Fe-NTA have negative effects on bone formation in vivo and in vitro, and that they are useful for experimental models for mineral induced osteomalacia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.